SUPER-REFRACTORY STATUS EPILEPTICUS
Clinical trials for SUPER-REFRACTORY STATUS EPILEPTICUS explained in plain language.
Never miss a new study
Get alerted when new SUPER-REFRACTORY STATUS EPILEPTICUS trials appear
Sign up with your email to follow new studies for SUPER-REFRACTORY STATUS EPILEPTICUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for patients with seizures that Won't stop?
Disease control CompletedThis study tested a drug called SAGE-547 in 25 people with super-refractory status epilepticus, a life-threatening condition where seizures continue despite standard treatments. The main goal was to check the drug's safety and how the body processes it. The study was completed, b…
Matched conditions: SUPER-REFRACTORY STATUS EPILEPTICUS
Phase: PHASE1, PHASE2 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 01, 2026 22:42 UTC
-
New hope for patients with Life-Threatening seizures that Won't stop
Disease control CompletedThis study tested a drug called SAGE-547 for people with super-refractory status epilepticus, a life-threatening condition where seizures continue despite strong medications. The trial included 132 participants aged 2 and older. The goal was to see if SAGE-547 could help patients…
Matched conditions: SUPER-REFRACTORY STATUS EPILEPTICUS
Phase: PHASE3 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 01, 2026 16:00 UTC